Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

The genetics of dementia with Lewy bodies: what are we missing?

Meeus B, Theuns J, Van Broeckhoven C.

Arch Neurol. 2012 Sep;69(9):1113-8. doi: 10.1001/archneurol.2011.3678. Review.

PMID:
22635379
2.

Regional Overlap of Pathologies in Lewy Body Disorders.

Colom-Cadena M, Grau-Rivera O, Planellas L, Cerquera C, Morenas E, Helgueta S, Muñoz L, Kulisevsky J, Martí MJ, Tolosa E, Clarimon J, Lleó A, Gelpi E.

J Neuropathol Exp Neurol. 2017 Mar 1;76(3):216-224. doi: 10.1093/jnen/nlx002.

PMID:
28395086
3.

Molecular pathology of Lewy body diseases.

Beyer K, Domingo-Sàbat M, Ariza A.

Int J Mol Sci. 2009 Mar;10(3):724-45. doi: 10.3390/ijms10030724. Epub 2009 Feb 26. Review.

4.

Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.

Zhou W, Milder JB, Freed CR.

J Biol Chem. 2008 Apr 11;283(15):9863-70. doi: 10.1074/jbc.M710232200. Epub 2008 Jan 30.

5.

Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.

Yamaguchi K, Cochran EJ, Murrell JR, Polymeropoulos MH, Shannon KM, Crowther RA, Goedert M, Ghetti B.

Acta Neuropathol. 2005 Sep;110(3):298-305. Epub 2005 Jun 25.

PMID:
15981014
6.

Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.

Gwinn-Hardy K, Mehta ND, Farrer M, Maraganore D, Muenter M, Yen SH, Hardy J, Dickson DW.

Acta Neuropathol. 2000 Jun;99(6):663-72.

PMID:
10867800
7.

Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.

Snider BJ, Norton J, Coats MA, Chakraverty S, Hou CE, Jervis R, Lendon CL, Goate AM, McKeel DW Jr, Morris JC.

Arch Neurol. 2005 Dec;62(12):1821-30.

PMID:
16344340
8.

Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.

Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K.

Neurosci Lett. 2010 Dec 3;486(1):19-23. doi: 10.1016/j.neulet.2010.09.036. Epub 2010 Sep 17.

PMID:
20851165
9.

Pathological roles of α-synuclein in neurological disorders.

Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L.

Lancet Neurol. 2011 Nov;10(11):1015-25. doi: 10.1016/S1474-4422(11)70213-7. Review. Erratum in: Lancet Neurol. 2011 Dec;10(12):1041.

PMID:
22014436
10.

Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.

Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Uéda K, Ikeda K, Kawai M.

Brain Res. 1999 Oct 2;843(1-2):53-61.

PMID:
10528110
11.

Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.

Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T.

Acta Neuropathol. 2002 Sep;104(3):225-30. Epub 2002 May 9.

PMID:
12172907
12.

The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.

Spillantini MG, Goedert M.

Ann N Y Acad Sci. 2000;920:16-27. Review.

PMID:
11193145
13.

Neuropathological spectrum of synucleinopathies.

Jellinger KA.

Mov Disord. 2003 Sep;18 Suppl 6:S2-12. Review.

PMID:
14502650
14.
15.

In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.

Fodero-Tavoletti MT, Mulligan RS, Okamura N, Furumoto S, Rowe CC, Kudo Y, Masters CL, Cappai R, Yanai K, Villemagne VL.

Eur J Pharmacol. 2009 Sep 1;617(1-3):54-8. doi: 10.1016/j.ejphar.2009.06.042. Epub 2009 Jul 1.

PMID:
19576880
16.

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chataway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, Chilcote TJ.

J Biol Chem. 2006 Oct 6;281(40):29739-52. Epub 2006 Jul 17.

17.
18.

Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.

Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW.

J Neuropathol Exp Neurol. 2003 Apr;62(4):389-97.

PMID:
12722831
19.

Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.

Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A.

J Neuropathol Exp Neurol. 2006 Mar;65(3):278-88.

PMID:
16651889
20.

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.

Jellinger KA.

Mov Disord. 2012 Jan;27(1):8-30. doi: 10.1002/mds.23795. Epub 2011 Nov 11. Review.

PMID:
22081500

Supplemental Content

Support Center